Keyphrases
Radiation Therapy
100%
Temozolomide
100%
Orthotopic Glioma
100%
Radiotherapy
75%
Standard of Care
50%
Glioblastoma multiforme
50%
Glioma Stem Cells
50%
Notch Inhibitor
50%
Chemotherapy
25%
Signaling Pathway
25%
Tumor Growth
25%
Combination Treatment
25%
Survival Benefit
25%
Xenograft Model
25%
Stem Cells
25%
Notch Signaling
25%
Radiation Resistance
25%
RO4929097
25%
Microcomputed Tomography
25%
Sex-determining Region Y-box 2 (SOX2)
25%
Dual Combination
25%
Cell Effects
25%
Glioma Cell Lines
25%
3D Spheroids
25%
Precision Radiotherapy
25%
Nestin
25%
Improved Survival
25%
Treatment Standards
25%
Spheroid Formation
25%
γ-secretase Inhibitor
25%
Temozolomide Resistance
25%
Stem Cell Markers
25%
Anti-glioma
25%
Primary Brain Tumor
25%
Tumor Growth in Vivo
25%
Clonogenic Survival
25%
Human Glioblastoma
25%
Image-guided
25%
CD133
25%
INIS
radiotherapy
100%
notches
100%
glioblastomas
100%
tumors
50%
stem cells
50%
growth
50%
gliomas
50%
reduction
16%
images
16%
surgery
16%
humans
16%
comparative evaluations
16%
brain
16%
radiations
16%
inhibition
16%
precision
16%
chemotherapy
16%
computerized tomography
16%
in vivo
16%
adults
16%
proliferation
16%
spheroids
16%
Medicine and Dentistry
Glioblastoma
100%
Temozolomide
100%
Radiation Therapy
100%
Tumor Progression
40%
Glioma Stem Cell
40%
Clinical Study
20%
Cell Marker
20%
Cell Signaling Pathway
20%
Xenograft
20%
Tumor Spheroid
20%
X-Ray Microtomography
20%
Radiosensitivity
20%
Brain Cancer
20%
N (6,7 Dihydro 6 Oxo 5h dibenz[b,d]azepin 7 Yl) 2,2 Dimethyl N' (2,2,3,3,3 Pentafluoropropyl)propanediamide
20%
Secretase
20%
Glioma Cell Line
20%
Nestin
20%
Stem Cell
20%
Neuroscience
Temozolomide
100%
Radiation Therapy
100%
Stem Cell
60%
Glioblastoma Multiforme
40%
Cell Line
20%
Behavior (Neuroscience)
20%
In Vivo
20%
Cell Signaling
20%
Secretase
20%
Nestin
20%
CD133
20%
SOX2
20%
Intracranial Tumor
20%